Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Chris Seaton, Bayer, on the pharma industry 5-year outlook

  • Broadcast in Business
  • 0 comments
WBR

WBR

×  

Follow This Show

If you liked this show, you should follow WBR.
h:81839
s:1259645
archived
Chris Seaton, Senior Vice President of Global Transactions at Bayer HealthCare Pharmaceuticals, talks with Kelly Hushin, Online Content Manager for Worldwide Business Research, producers of BioNetwork, about how the pharma industry will deal with the issues surrounding healthcare reform, the economic recession, industry consolidation and other changes that will continue throughout the industry.

BioNetwork is a three-day partnering event for biotech and pharmaceutical companies that facilitates partnering conversations through one-to-one meetings and extended networking activities.

Seaton is a speaker at the 2010 event, which takes place October 25 to 27, 2010 at the Ritz-Carlton in Laguna Niguel, CA. You can visit the website at ? www.bionetworkus.com? to take a look at other speakers joining him.

Comments

 comments